Altria Group, Inc. (MO)
Why Altria Stock Was Sliding Today
Shares of Altria (MO -3.11%), the tobacco giant best known as the domestic maker of Marlboro cigarettes, were heading lower after its guidance for 2025 disappointed investors.
Here's What Key Metrics Tell Us About Altria (MO) Q4 Earnings
Although the revenue and EPS for Altria (MO) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Altria (MO) Surpasses Q4 Earnings and Revenue Estimates
Altria (MO) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.18 per share a year ago.
Altria sees weak annual profit as vape competition heats up
Marlboro maker Altria said on Thursday its annual adjusted profit could be lower than estimated, citing rising competition from rival vapes in the market and persistently weaker demand for cigarettes.
Altria 'smoke-free' targets under threat from illicit vapes
Altria , the maker of Marlboro cigarettes, has placed under review its 2028 goals for selling alternatives to smoking on the U.S. market, saying on Thursday it may not be able to meet them because of competition from disposable vapes.
Altria says counterfeit e-vape products are hurting its business outlook
“Illicit products now represent more than 60% of the e-vapor category,” the tobacco company said.
Altria Group Stock Dips on Decline in Cigarette Volumes
Altria Group, the maker of tobacco products, posts quarterly earnings in line with expectations.
Is Altria Group (MO) Stock Outpacing Its Consumer Staples Peers This Year?
Here is how Altria (MO) and Simply Good Foods (SMPL) have performed compared to their sector so far this year.
Altria: Expect To Be Paid ~10% Yield Also In 2025
Altria Group, Inc.'s Q4 earnings are expected to meet or exceed consensus, driven by strong pricing power and operational efficiencies offsetting cigarette volume declines. Looking to 2025, Altria remains positioned to generate $8.3 billion in attributable cash flow, likely sustaining a highly attractive ~10% shareholder yield. As a key risk factor, GLP-1 medications could accelerate cigarette volume declines by reducing nicotine cravings, posing a potential long-term challenge for Altria.
Altria Gears Up for Q4 Earnings: Here's What You Should Understand
MO's Q4 results are likely to reflect gains from pricing actions and strength in NJOY and on! amid shifting consumer preferences.
Best Stock to Buy Right Now: Altria vs. Costco
Altria (MO 1.64%) and Costco (COST -0.26%) are pretty different companies, but they share a subtle similarity. What is that similarity?
Altria (MO) Outperforms Broader Market: What You Need to Know
In the latest trading session, Altria (MO) closed at $51.21, marking a +0.79% move from the previous day.
